180 related articles for article (PubMed ID: 36348333)
1. Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database.
Park B; Lee H; Park S; Lee ES; Lee JJ; Lee Y; Seo JH
BMC Womens Health; 2022 Nov; 22(1):439. PubMed ID: 36348333
[TBL] [Abstract][Full Text] [Related]
2. Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.
Mahmoud SA; Zhang L; Jia C; Zang H
J Reprod Med; 2016; 61(5-6):302-5. PubMed ID: 27424378
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility.
Charalampakis V; Tahrani AA; Helmy A; Gupta JK; Singhal R
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():220-226. PubMed ID: 27773356
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
[TBL] [Abstract][Full Text] [Related]
5. Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR‑223/GLUT4 and SNHG20/miR‑4486/GLUT4 signaling.
Liu J; Zhao Y; Chen L; Li R; Ning Y; Zhu X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35552758
[TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic characteristics of endometrial lesions in polycystic ovary syndrome at reproductive age.
Zhong X; Li Y; Liang W; Hu Q; Zeng A; Ding M; Chen D; Xie M
BMC Womens Health; 2023 May; 23(1):236. PubMed ID: 37149578
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea.
Tingthanatikul Y; Choktanasiri W; Rochanawutanon M; Weerakeit S
Gynecol Endocrinol; 2006 Feb; 22(2):101-5. PubMed ID: 16603436
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy complications and endometrial cancer in women with polycystic ovarian syndrome: a Korean National Health Insurance Service study.
Kim JH; Jung MH; Moon N; Hong SH; Kang DR
Int J Gynecol Cancer; 2023 Oct; 33(10):1580-1586. PubMed ID: 37479466
[TBL] [Abstract][Full Text] [Related]
9. Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience.
Wang Y; Nisenblat V; Tao L; Zhang X; Li H; Ma C
J Gynecol Oncol; 2019 May; 30(3):e49. PubMed ID: 30887764
[TBL] [Abstract][Full Text] [Related]
10. Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer.
Beavis AL; Blechter B; Najjar O; Fader AN; Katebi Kashi P; Rositch AF
Gynecol Oncol; 2023 Jul; 174():98-105. PubMed ID: 37172411
[TBL] [Abstract][Full Text] [Related]
11. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
Shafiee MN; Khan G; Ariffin R; Abu J; Chapman C; Deen S; Nunns D; Barrett DA; Seedhouse C; Atiomo W
Gynecol Oncol; 2014 Jan; 132(1):248-53. PubMed ID: 24183733
[TBL] [Abstract][Full Text] [Related]
12. Risk of developing major depressive disorder in polycystic ovary syndrome: a retrospective cohort study.
Lee IO; Kim JC; Seo JW; Pak HY; Chung JE
J Obstet Gynaecol; 2021 Oct; 41(7):1157-1161. PubMed ID: 33645403
[TBL] [Abstract][Full Text] [Related]
13. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ
Medicine (Baltimore); 2018 Sep; 97(39):e12608. PubMed ID: 30278576
[TBL] [Abstract][Full Text] [Related]
14. The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern.
Prakansamut N; Sirayapiwat P; Triratanachat S
J Med Assoc Thai; 2014 Feb; 97(2):159-64. PubMed ID: 24765893
[TBL] [Abstract][Full Text] [Related]
15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome.
Joham AE; Kakoly NS; Teede HJ; Earnest A
J Clin Endocrinol Metab; 2021 May; 106(6):1585-1593. PubMed ID: 33693653
[TBL] [Abstract][Full Text] [Related]
17. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
Ding T; Hardiman PJ; Petersen I; Baio G
Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of endometrial hyperplasia.
Armstrong AJ; Hurd WW; Elguero S; Barker NM; Zanotti KM
J Minim Invasive Gynecol; 2012; 19(5):562-71. PubMed ID: 22863972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
